Språk: en

All-time high in QuickMIC® abstracts at ECCMID 2024

The diagnostics company Gradientech today announces that six QuickMIC® abstracts will be presented at the 34th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Barcelona, Spain 27-30 April 2024.

Gradientech announces oversubscribed rights issue

Gradientech AB (publ) announces that the company’s rights issue, for which the subscription period ended on December 6, 2023, has been completed. The issue was oversubscribed amounting to a total of approximately 107 percent. Through the issue, Gradientech will receive the maximum planned amount of approximately SEK 25.8 million before deduction of issue costs.

Investor meeting, 27 November

On 27 November 2023 we will host an investor presentation in Stockholm where we will inform about the issue and provide a business update. Our Italian distributor a.d.a. and Stefan Willemsen, the company’s strategic advisor in the US, will also give their views on the respective markets and the potential for QuickMIC. You are warmly […]

Arkiv

Next-generation antimicrobial susceptibility testing

Take a look at our E-book